[ Price : $8.95]
Industry associations sound alarms and frustrations as they weigh how FDA staff cuts will impact product development, FDA reviews ...[ Price : $8.95]
Roche says the Phase 3 MUSETTE study found that a higher dose of Ocrevus IV did not provide more benefit than the approved 600 mg ...[ Price : $8.95]
Edgewise Therapeutics says its EDG-7500 achieved positive results in the four-week CIRRUS-HCM trial in hypertrophic cardiomyopathy...[ Price : $8.95]
The Senate HELP Committee invites HHS secretary RFK, Jr., to testify on his reorganization of the department.[ Price : $8.95]
FDA misses its 4/1 user fee review action target date on a Novavax BLA seeking full approval for its current Covid-19 vaccine.[ Price : $8.95]
FDA says it is reprioritizing planned inspections for the rest of the year due to challenges it faces after 170 administrative and...[ Price : $8.95]
FDA clears a Medivis 510(k) for its Spine Navigation platform that uses augmented reality and artificial intelligence (AI) to assi...[ Price : $8.95]
HHS begins terminating FDA employees, with many receiving email notifications in the early morning hours or being denied entrance ...